首页|局部枸橼酸抗凝在双重血浆分子吸附系统治疗肝衰竭患者的有效性及安全性

局部枸橼酸抗凝在双重血浆分子吸附系统治疗肝衰竭患者的有效性及安全性

扫码查看
目的:比较局部枸橼酸抗凝(regional citrate anticoagulation,RCA)及肝素抗凝(heparin anticoagula-tion,HA)在双重血浆分子吸附系统(double plasma molecule adsorb system,DPM AS)中的有效性及安全性.方法:纳入2021年1月-2023年7月在徐州医科大学附属医院EICU就诊的肝衰竭患者101例,按照纳入、排除标准共入组76例患者.根据肝衰竭诊断的时间顺序,按随机数字顺序表法将入组患者分为局部枸橼酸组(RCA组)37例和肝素组(HA组)39例,其中RCA组4例患者和HA组6例未完成观察,每组最终各纳入33例.记录两组患者一般资料,观察肝功能、凝血功能、血氨(blood ammonia,NH3)、血气分析及并发症情况,比较DPMAS治疗后的总胆红素(total bilirubin,TBIL)及NH3清除率、凝血酶原活动度(prothrombin time activity,PTA)升高率;比较两组治疗有效率、并发症发生率,分析28 d生存率.结果:DPMAS治疗后两组患者治疗有效率、治疗前后TBIL、NH3、PTA以及治疗前后三者的变化率比较,差异无统计学意义(P>0.05);与治疗前比较,治疗后两组TBIL、NH3下降,PTA升高,差异有统计学意义(P<0.05).枸橼酸蓄积以血清总钙/离子钙≥2.5为评判标准,RCA组在治疗结束时出现22次,在治疗结束后1 d无枸橼酸蓄积;RCA组出血及血小板减少并发症发生率低于HA组,差异有统计学意义(P<0.05);两组其余并发症发生率比较,差异无统计学意义(P>0.05);两组治疗前后酸碱度、电解质指标及治疗结束后28 d生存率比较,差异无统计学意义(P>0.05).结论:行局部枸橼酸抗凝的DPMAS治疗与肝素抗凝治疗的有效率相似,但前者可降低出血及血小板减少发生率.
Efficacy and safety of regional citrate anticoagulation in double plasma molecule adsorb system in patients with liver failure
Objective:To compare the efficacy and safety of regional citrate anticoagulation(RCA)and heparin anticoagulation(HA)in double plasma molecule adsorb system(DPMAS).Methods:One hundred and one pa-tients with liver failure who attended the EICU from January 2021 to July 2023 were included.According to the chronological order of liver failure diagnosis,the enrolled patients were divided into two groups using a random number table:the regional citrate anticoagulation(RCA)group with 37 cases and the heparin anticoagulation(HA)group with 39 cases,and 33 cases were finally included in each group according to the inclusion and exclu-sion criteria.The general data of the two groups,observe the liver function,coagulation function,blood ammonia(NH3),blood gas analysis and complications,compare the total bilirubin(TBIL)and NH3 clearance rate,pro-thrombin time activity(PTA)elevation rate after DPMAS treatment,compare the effective rate of treatment,complication rate,and analyse the 28-day cumulative survival rate of the two groups.Results:There was no sta-tistically significant difference in the treatment efficiency,TB1L,NH3,PTA before and after treatment,and the rate of change of the three before and after treatment between the two groups of patients after DPMAS treatment(P>0.05).TBIL,NH3 decreased and PTA increased in the two groups after treatment,compared with those be-fore treatment(P<0.05).Citrate accumulation(serum total calcium/ionize calcium ≥ 2.5)was presented 22 times in the RCA group by the end of treatment,and disappeared 1 day after the end of treatment.The complica-tion rates of bleeding and thrombocytopenia were lower in the RCA group than those in the HA group(P<0.05).The difference in the rates of the remaining complications was not statistically significant(P>0.05).There was no statistically significant difference between the two groups in acid-base electrolyte indices and 28-days survival rate after the end of treatment.Conclusion:The effective rate of DPMAS with RCA is similar to that with HA,but the former reduces the incidence of bleeding and thrombocytopenia.

liver failuredouble plasma molecule absorb systemanticoagulantcitratecontinuous renal re-placement therapyheparin

郭思妍、薛婷、李丽、邱小松、燕宪亮、叶英

展开 >

徐州医科大学附属医院急诊医学科(江苏徐州,221002)

肝功能衰竭 双重血浆分子吸附系统 抗凝 枸橼酸 持续肾脏替代治疗 肝素

2024

临床急诊杂志
华中科技大学同济医学院

临床急诊杂志

CSTPCD
影响因子:0.652
ISSN:1009-5918
年,卷(期):2024.25(12)